# v5.2\n\n## Related releases\n\n## Data changes\n

### Gene

```
CXCR4 Background Updated
OGA Background Updated
OGA Summary Updated
OGT Background Updated
OGT Summary Updated
PDK1 Background Updated
PDK1 Summary Updated
RSPO2 Background Updated
RSPO2 Summary Updated
RSPO3 Background Updated
RSPO3 Summary Updated
VEGFB Background Updated
VEGFB Summary Updated
```

### Alteration

```
ALK Fusions, Mutation Effect, Description Updated
BRIP1 A349P (germline) Deleted
CDKN2A V126D, Mutation Effect, Description Updated
CDKN2A V126D, Mutation Effect, Effect Updated
	 New: Likely Loss-of-function
	 Old:
CDKN2A V126D, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CDKN2A V126D Added
CRLF2 F232C, Mutation Effect, Description Updated
CTNNB1 Q28_D81del, Mutation Effect, Description Updated
CTNNB1 Q28_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 Q28_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 Q28_D81del Added
CTNNB1 A5_D81del, Mutation Effect, Description Updated
CTNNB1 A5_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_D81del Added
CTNNB1 M12_D81del, Mutation Effect, Description Updated
CTNNB1 M12_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 M12_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 M12_D81del Added
CTNNB1 A5_Q72del, Mutation Effect, Description Updated
CTNNB1 A5_Q72del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_Q72del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_Q72del Added
CTNNB1 S29_D81del, Mutation Effect, Description Updated
CTNNB1 S29_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 S29_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 S29_D81del Added
CTNNB1 E9_D81del, Mutation Effect, Description Updated
CTNNB1 E9_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 E9_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 E9_D81del Added
CTNNB1 A5_G69del, Mutation Effect, Description Updated
CTNNB1 A5_G69del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_G69del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_G69del Added
CTNNB1 A5_Q79del, Mutation Effect, Description Updated
CTNNB1 A5_Q79del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_Q79del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_Q79del Added
CTNNB1 A2_D81del, Mutation Effect, Description Updated
CTNNB1 A2_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A2_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A2_D81del Added
CTNNB1 Q4_D81del, Mutation Effect, Description Updated
CTNNB1 Q4_D81del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 Q4_D81del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 Q4_D81del Added
CTNNB1 A5_Q68del, Mutation Effect, Description Updated
CTNNB1 A5_Q68del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_Q68del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_Q68del Added
CTNNB1 A5_A97del, Mutation Effect, Description Updated
CTNNB1 A5_A97del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_A97del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_A97del Added
CTNNB1 A5_F70del, Mutation Effect, Description Updated
CTNNB1 A5_F70del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_F70del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_F70del Added
CTNNB1 A5_E9del, Mutation Effect, Description Updated
CTNNB1 A5_E9del, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
CTNNB1 A5_E9del, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
CTNNB1 A5_E9del Added
EGFR R958* [vV] Name Changed
	 New: R958* [vV]
	 Old: vV
EGFR D770_N771insNPG, Mutation Effect, Description Updated
EGFR D770_N771insNPG, Mutation Effect, Oncogenic Updated
	 New: Yes
	 Old: Likely
ERBB2 L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations) Name Changed
	 New: L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations)
	 Old: V697L, Q709L, A710V, E717D, L726F, L726I, T733I, L768S, L755A, L755P, L755S, L755W, I767M, D769H, D769Y, V773L, G776S, G776V, V777L, V777M, V794M, T798M, D808N, G815R, D821N, L841V, V842I, L866M, L869R, 770_831ins (Tyrosine Kinase Domain Activating Mutations)
ERBB2 A710V, Mutation Effect, Description Updated
ERBB2 Q709L, Mutation Effect, Description Updated
ERBB2 V697L, Mutation Effect, Description Updated
ESR1 V422del (Oncogenic ligand-binding domain in-frame insertions or deletions), Mutation Effect, Description Updated
ESR1 V422del (Oncogenic ligand-binding domain in-frame insertions or deletions), Mutation Effect, Effect Updated
	 New: Gain-of-function
	 Old:
ESR1 V422del (Oncogenic ligand-binding domain in-frame insertions or deletions), Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
FGFR2 FGFR2-OGA Fusion, Mutation Effect, Description Updated
FGFR2 FGFR2-OGA Fusion Name Changed
	 New: FGFR2-OGA Fusion
	 Old: FGFR2-MGEA5 Fusion
H3C2 K28M Added
H3C3 K28M Added
MAP2K1 E114_L115del, Mutation Effect, Description Updated
MAP2K1 E114_L115del, Mutation Effect, Effect Updated
	 New: Likely Neutral
	 Old: Inconclusive
MAP2K1 E114_L115del, Mutation Effect, Oncogenic Updated
	 New: Likely Neutral
	 Old: Inconclusive
MAP2K1 E114_L115del Deleted
MLH1 T117M, Mutation Effect, Description Updated
MLH1 T117M, Mutation Effect, Effect Updated
	 New: Loss-of-function
	 Old: Gain-of-function
OGA S652F, Mutation Effect, Description Updated
OGA S652F, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
OGA S652F, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
OGA S652F Added
OGA R586A, Mutation Effect, Description Updated
OGA R586A, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
OGA R586A, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
OGA R586A Added
OGT Amplification, Mutation Effect, Description Updated
OGT Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
OGT Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
OGT Amplification Added
PDK1 Amplification, Mutation Effect, Description Updated
POLD1 E245K, Mutation Effect, Description Updated
POLD1 E245K, Mutation Effect, Effect Updated
	 New: Inconclusive
	 Old: Likely Loss-of-function
POLD1 E245K, Mutation Effect, Oncogenic Updated
	 New: Inconclusive
	 Old: Likely
RSPO2 Fusion, Mutation Effect, Description Updated
RSPO2 Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO2 Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO2 Fusion Added
RSPO2 Amplification, Mutation Effect, Description Updated
RSPO2 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO2 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO2 Amplification Added
RSPO2 Fusions Name Changed
	 New: Fusions
	 Old: Fusion
RSPO2 EIF3E-RSPO2 Fusion, Mutation Effect, Description Updated
RSPO2 EIF3E-RSPO2 Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO2 EIF3E-RSPO2 Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO2 EIF3E-RSPO2 Fusion Added
RSPO2 EMC2-RSPO2 Fusion, Mutation Effect, Description Updated
RSPO2 EMC2-RSPO2 Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO2 EMC2-RSPO2 Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO2 EMC2-RSPO2 Fusion Added
RSPO2 PVT1-RSPO2 Fusion, Mutation Effect, Description Updated
RSPO2 PVT1-RSPO2 Fusion, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO2 PVT1-RSPO2 Fusion, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO2 PVT1-RSPO2 Fusion Added
RSPO3 Amplification, Mutation Effect, Description Updated
RSPO3 Amplification, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO3 Amplification, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO3 Amplification Added
RSPO3 Fusions, Mutation Effect, Description Updated
RSPO3 Fusions, Mutation Effect, Effect Updated
	 New: Likely Gain-of-function
	 Old:
RSPO3 Fusions, Mutation Effect, Oncogenic Updated
	 New: Likely
	 Old:
RSPO3 Fusions Added
```

### Evidence

```
ERBB2 Amplification, Esophagogastric Adenocarcinoma Name Changed
	 New: Esophagogastric Adenocarcinoma
	 Old: Esophagogastric Cancer
ERBB2 E717D, Summary Updated
ERBB2 A710V, Summary Updated
ERBB2 Q709L, Summary Updated
ERBB2 V697L, Summary Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Summary Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Zongertinib, Description Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Zongertinib, FDA Level Updated
	 New: Fda2
	 Old: Fda3
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Zongertinib, Level Updated
	 New: 2
	 Old: 3A
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Sevabertinib, Description Updated
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Description Updated
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, FDA Level Updated
	 New: Fda2
	 Old: no
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Summary Updated
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Level Updated
	 New: 1
	 Old:
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Liquid Tumor Types Updated
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Solid Tumor Types Updated
H3-3A K28M, Diffuse Intrinsic Pontine Glioma Added
H3-3A K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone 1 Added
H3-3A K28M, Diffuse Intrinsic Pontine Glioma Deleted
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Summary Updated
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Description Updated
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, FDA Level Updated
	 New: Fda2
	 Old: no
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Level Updated
	 New: 1
	 Old:
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Liquid Tumor Types Updated
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Solid Tumor Types Updated
H3C2 K28M, Diffuse Intrinsic Pontine Glioma Added
H3C2 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone 1 Added
H3C2 K28M, Diffuse Intrinsic Pontine Glioma Deleted
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Summary Updated
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Description Updated
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, FDA Level Updated
	 New: Fda2
	 Old: no
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Level Updated
	 New: 1
	 Old:
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Liquid Tumor Types Updated
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone, Propagation to Other Solid Tumor Types Updated
H3C3 K28M, Diffuse Intrinsic Pontine Glioma Added
H3C3 K28M, Diffuse Intrinsic Pontine Glioma, Dordaviprone 1 Added
H3C3 K28M, Diffuse Intrinsic Pontine Glioma Deleted
KRAS Oncogenic Mutations, Low-Grade Serous Ovarian Cancer, Avutometinib + Defactinib, Description Updated
KRAS G12C, Colorectal Cancer, Sotorasib + Panitumumab, Description Updated
NF1 Oncogenic Mutations, Neurofibroma, Summary Updated
NF1 Oncogenic Mutations, Neurofibroma, Selumetinib, Description Updated
NF1 Oncogenic Mutations, Neurofibroma, Selumetinib, Additional Information Updated
OGA Gene Type, Oncogene Updated
OGT Gene Type, Oncogene Updated
PDGFRA 814_852mis [Exon 18 missense mutations], 814_852del [Exon 18 in-frame deletions], 814_852ins [Exon 18 in-frame insertions] (Exon 18 mutations), Gastrointestinal Stromal Tumor, Avapritinib, Description Updated
RSPO2 Gene Type, Oncogene Updated
RSPO3 Gene Type, Oncogene Updated
VEGFB Gene Type, Oncogene Updated
```
